Advertisement

Understanding the Haemodynamics of Hypertension

  • B. E. Smith
  • V. M. Madigan
Hypertension and Emergency Medicine (T Rainer and P Levy, Section Editors)
  • 247 Downloads
Part of the following topical collections:
  1. Topical Collection on Hypertension and Emergency Medicine

Abstract

Purpose of review

This article introduces the haemodynamic principles that underpin the pathophysiology of hypertension and introduces a rational physiological approach to appropriate pharmacologic treatment.

Recent findings

Outdated understanding of haemodynamics based on previous measurement systems can no longer be applied to our understanding of the circulation. We question the current view of hypertension as defined by a predominantly systolic blood pressure and introduce the concept of vasogenic, cardiogenic and mixed-origin hypertension. We postulate that failure to identify the individual’s haemodynamic pattern may lead to the use of inappropriate medication, which in turn may be a major factor in patient non-compliance with therapeutic strategies. A population-based approach to treatment of hypertension may lead to suboptimal functional dynamics in the individual patient. Finally, we question the validity of current guidelines and published evidence relating morbidity and mortality to the future treatment of hypertension.

Summary

The importance of individual haemodynamic profiles may be pivotal in the understanding, diagnosis and treatment of hypertension if optimal control with minimal adverse effects is to be achieved. Research based on individual haemodynamic patterns is overdue.

Keywords

Blood pressure Cardiac output Compliance Haemodynamics Hypertension Pathophysiology Vascular resistance 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare no conflicts of interest. Specifically, neither of the authors has any financial interest in any company or organisation, nor has received any financial benefit or inducement related to the subject matter of this review article.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. 1.
    •• Phillips RA, Smith BE, Madigan VM. Stroke volume monitoring: novel continuous wave doppler parameters, algorithms and advanced noninvasive haemodynamic concepts. Curr Anesthesiol Rep. 2017;7(4):387–98.  https://doi.org/10.1007/s40140-017-0235-4. This review summarises the methods available to the clinician to evaluate haemodynamics using non- and minimally-invasive methods. It includes the basic science of Doppler methods and echocardiography, along with the strengths and limitations of each method. CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Lin ACW, Lowe A, Sidhu K, Harrison W, Ruygrok P, Stewart R. Evaluation of a novel sphygmomanometer, which estimates central aortic blood pressure from analysis of brachial artery suprasystolic pressure waves. J Hypertens. 2012;30(9):1743–50.  https://doi.org/10.1097/HJH.0b013e3283567b94.CrossRefPubMedGoogle Scholar
  3. 3.
    Robin ED. The cult of the Swan-Ganz catheter: overuse and abuse of pulmonary flow catheters. Ann Intern Med. 1985;103(3):445–9.  https://doi.org/10.7326/0003-4819-103-3-445.CrossRefPubMedGoogle Scholar
  4. 4.
    •• Hall JB. Searching for evidence to support pulmonary artery catheter use in critically ill patients. JAMA. 2005;294(13):1693–4. Although a little dated, this editorial from 2005, some 35 years after the introduction of the pulmonary artery catheter (PAC), discusses the evidence in terms of patient outcomes and the impact, or more accurately, lack of impact, of the PAC. Although often considered or referred to as the “gold standard” of haemodynamic monitoring and cardiac output measurement, in fact there is little evidence to support this view. The ESCAPE trial which was terminated early due to excessive adverse effects in the PAC group is also discussed, as is the case for using non-PAC methods of evaluating haemodynamics. CrossRefPubMedGoogle Scholar
  5. 5.
    Marik P. Obituary: pulmonary artery catheter 1970 to 2013. Ann Intensive Care. 2013;3(1):38.  https://doi.org/10.1186/2110-5820-3-38.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Phillips RA, Hood SG, Jacobson BM, West MJ, Wan L, May CN. Pulmonary artery catheter (PAC) accuracy and efficacy compared with flow probe and transcutaneous Doppler (USCOM): an ovine cardiac output validation. Critical Care Research and Practice, vol. 2012, Article ID 621496, 9 pages, 2012.  https://doi.org/10.1155/2012/621496
  7. 7.
    •• Sramek BB. Haemodynamic management. http://www.hemodynamicsociety.org/hemodynamicmanagement.html#Per-beat_Hemodynamics. This on-line paper is a good primer in basic haemodynamics and cardiovascular physiology. The haemodynamic neophyte should read this relatively brief introduction to the science before proceeding to the more complex matters dealt with later in this review.
  8. 8.
    •• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;  https://doi.org/10.1016/j.jacc.2017.11.006. A heavy document but an excellent source of information and evidence underpinning the current thinking regarding the treatment of hypertension. Remarkably, the document does not contain any of the following phrases: hemodynamics, cardiac output, cardiac index, stroke volume, vascular resistance or vascular impedance. The same is also true of reference 9.
  9. 9.
    2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925–38.  https://doi.org/10.1097/HJH.0b013e328364ca4c.CrossRefGoogle Scholar
  10. 10.
    Bergmark BA, Scirica BM, Steg PG, Fanola CL, Gurmu Y, Mosenzon O, et al. SAVOR-TIMI 53 Investigators. Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk. Eur Heart J. 2018;  https://doi.org/10.1093/eurheartj/ehx809.
  11. 11.
    Bhatt DL. Troponin and the J-curve of diastolic blood pressure when lower is not better. J Am Coll Cardiol. 2016;68(16):1723–6.CrossRefPubMedGoogle Scholar
  12. 12.
    McEvoy JW, Chen Y, Rawlings A, et al. Diastolic blood pressure, subclinical myocardial damage, and cardiac events: implications for blood pressure control. J Am Coll Cardiol. 2016;68(16):1713–22.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Selvaraj S, Steg PG, Elbez Y, et al. Pulse pressure and risk for cardiovascular events in patients with Atherothrombosis: from the REACH Registry. J Am Coll Cardiol. 2016;67(4):392–403.  https://doi.org/10.1016/j.jacc.2015.10.084.CrossRefPubMedGoogle Scholar
  14. 14.
    Smith BE, Madigan V. Non-invasive method for rapid bedside estimation of inotropy: theory and preliminary clinical validation. Brit J Anaesth. 2013;111(4):580–8.  https://doi.org/10.1093/bja/aet118.CrossRefPubMedGoogle Scholar
  15. 15.
    Smith BE. Rapid non-invasive determination of ventricular preload. Anaesth Intensive Care. 2008;36(4):609.Google Scholar
  16. 16.
    Milnor WR. Arterial impedance as ventricular afterload. Circ Res. 1975;36(5):565–70.CrossRefPubMedGoogle Scholar
  17. 17.
    Tarazi RC, Levy MN. Cardiac responses to increased afterload. State-of-the-art review. Hypertension. 1982;4(3 Pt 2):8–18.PubMedGoogle Scholar
  18. 18.
    Lang RM, Borow KM, Neumann A, et al. Systemic vascular resistance: an unreliable index of left ventricular afterload. Circulation. 1986;74:1114–23.CrossRefPubMedGoogle Scholar
  19. 19.
    Elzinga G, Westerhof N. Pressure and flow generated by the left ventricle against different impedances. Circ Res. 1973;32:178–86.CrossRefPubMedGoogle Scholar
  20. 20.
    Kelly R, Fitchett D. Noninvasive determination of aortic input impedance and external left ventricular power output: a validation and repeatability study of a new technique. J Am Coll Cardiol. 1992;20:952–63.CrossRefPubMedGoogle Scholar
  21. 21.
    Solomon S, Katz SD, Stevenson-Smith W, Yellin EL, LeJemtel TH. Determination of vascular impedance in the peripheral circulation by transcutaneous pulsed Doppler ultrasound. Chest. 1995;108(2):515–21.CrossRefPubMedGoogle Scholar
  22. 22.
    Kelly RP, Ting CT, Yang TM, et al. Effective arterial elastance as index of arterial vascular load in humans. Circulation. 1992;86(2):513–21.  https://doi.org/10.1161/01.CIR.86.2.513.CrossRefPubMedGoogle Scholar
  23. 23.
    Westerhof N, Lankhaar JW, Westerhof BE. The arterial Windkessel. Med Biol Eng Comput. 2009;47:131–41.  https://doi.org/10.1007/s11517-008-0359-2.CrossRefPubMedGoogle Scholar
  24. 24.
    Chemla D, Antony I, LeCarpentier Y, Nitenberg A. Contribution of systemic vascular resistance and total arterial compliance to effective arterial elastance in humans. Am J Phys. 2003;285(2):H614–20.  https://doi.org/10.1152/ajpheart.00823.2002.Google Scholar
  25. 25.
    Hannah J, Hillier M. Applied mechanics. 3rd ed. United Kingdom: Pearson; 1995. p. 180–210.Google Scholar
  26. 26.
    O’Malley J. Schaum’s outline of basic circuit analysis. 2nd ed. New York: McGraw-Hill; 2011. p. 232–8.Google Scholar
  27. 27.
    Chan SS, Tse MM, Chan CP, Tai MC, Graham CA, Rainer TH. Haemodynamic changes in emergency department patients with poorly controlled hypertension. Hong Kong Med J. 2016;22(2):116–23.  https://doi.org/10.12809/hkmj154566.PubMedGoogle Scholar
  28. 28.
    Smith RD, Levy P, Ferrario CM, Consideration of Noninvasive Hemodynamic Monitoring to Target Reduction of Blood Pressure Levels Study Group. Value of noninvasive hemodynamics to achieve blood pressure control in hypertensive subjects. Hypertension. 2006;47(4):771–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Chacon-Lozsán F. Non-invasive hemodynamic analyses to guide pharmacotherapy of high blood pressure: mini-review. J Cardiol Cardiovasc Ther. 2017;3(3):555614.  https://doi.org/10.19080/JOCCT.2017.03.555614.Google Scholar
  30. 30.
    Sramek B, Tichy J, Hojerova M, Cervenka V. Normohemodynamic goal-orientes antihypertensive therapy improves the outcome. Am J Hypertens. 1996;9:141A.CrossRefGoogle Scholar
  31. 31.
    Taler S, Textor S, Augustine J. Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension. 2002;39(5):982–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Sharman DL, Gomes CP, Rutherford JP. Improvement in blood pressure control with impedance cardiography-guided pharmacologic decision making. Congest Heart Fail. 2004;10(1):54–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Smith R, Levy P, Ferrario C. Value of noninvasive hemodynamics to archive blood pressure control in hypertensive subjects. Hypertension. 2006;47(4):771–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Krzesiński P, Gielerak G, Stańczyk A, Piotrowicz K, Skrobowski A. Who benefits more from hemodynamically guided hypotensive therapy? The experience from two randomized, prospective and controlled trials. Ther Adv Cardiovasc Dis. 2016;10(1):21–9.  https://doi.org/10.1177/1753944715618593.CrossRefPubMedGoogle Scholar
  35. 35.
    •• Taler SJ. Individualizing antihypertensive combination therapies: clinical and hemodynamic considerations. Curr Hypertens Rep. 2014;16(7):451.  https://doi.org/10.1007/s11906-014-0451-y. A relatively short review of the evidence, but the article is long on common sense and evidence-based approaches to investigation, diagnosis and treatment of hypertension. Professor Taler concludes that current guidelines offer limited guidance beyond selection of the first and possibly second treatment agents. Meanwhile, haemodynamic measurements can be obtained efficiently, non-invasively and serially. CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Huntsman LL, Stewart DK, Barnes SR, Franklin SB, Colocousis JS, Hessel EA. Noninvasive Doppler determination of cardiac output in man. Clinical validation. Circulation. 1983;67(3):593–602.CrossRefPubMedGoogle Scholar
  37. 37.
    Crossingham IR, Nethercott DR, Columb MO. Comparing cardiac output monitors and defining agreement: a systematic review and meta-analysis. J Intensive Care Soc. 2016;17(4):302–13.  https://doi.org/10.1177/1751143716644457.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Critchley LA, Lee A, Ho AM-H. A critical review of the ability of continuous cardiac output monitors to measure trends in cardiac output. Anesth Analg. 2010;111:1180–92.CrossRefPubMedGoogle Scholar
  39. 39.
    Marik PE. Noninvasive cardiac output monitors: a state-of the-art review. J Cardiothorac Vasc Anesth. 2013;27(1):121–34.  https://doi.org/10.1053/jvca.2012.03.022.CrossRefPubMedGoogle Scholar
  40. 40.
    Franklin DL, Schlegel W, Rushmer RF. Blood flow measured by Doppler frequency shift of back scattered ultrasound. Science. 1961;134:564–5.CrossRefPubMedGoogle Scholar
  41. 41.
    •• Hatle L, Angelsen B. Doppler ultrasound in cardiology. Physical principles and applications. Philadelphia: Lea and Febiger; 1982. p. 192. A seminal work that should be compulsory reading for anybody intending to use echocardiography or Doppler techniques to measure volume flows in the heart. The scientific basis of the methods and more importantly, the limitations and pitfalls of the techniques are well explained and are both enlightening and sobering. This should be viewed along with reference 42 for a more complete understanding of the issues involved in using echocardiographic techniques at the point of care. Google Scholar
  42. 42.
    Quinones MA, et al. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002;15(2):167–84.CrossRefPubMedGoogle Scholar
  43. 43.
    Kusumoto F, Venet T, Schiller NB, Sebastian A, Foster E. Measurement of aortic blood flow by Doppler echocardiography: temporal, technician, and reader variability in normal subjects and the application of generalizability theory in clinical research. J Am Soc Echocardiog. 1995;8(5Pt1):647–53.CrossRefGoogle Scholar
  44. 44.
    Elgendy A, Seppelt IM, Lane AS. Comparison of continous-wave Doppler ultrasound monitor and echocardiography to assess cardiac output in intensive care patients. Crit Care Resusc. 2017;19(3):222–9.PubMedGoogle Scholar
  45. 45.
    He SR, Zhang C, Liu YM, Sun YX, Zhuang J, Chen JM, et al. Accuracy of the ultrasonic cardiac output monitor in healthy term neonates during postnatal circulatory adaptation. Chin Med J. 2011;124(15):2284–9.PubMedGoogle Scholar
  46. 46.
    Cattermole GN, Leung PY, Ho GY, Lau PW, Chan CP, Chan SS, Smith BE, Graham CA, Rainer TH. The normal ranges of cardiovascular parameters measured using the ultrasonic cardiac output monitor. Physiol Rep. 2017;5(6).  https://doi.org/10.14814/phy2.13195.
  47. 47.
    He SR, Sun X, Zhang C, Jian Z, Sun YX, Zheng ML, et al. Measurement of systemic oxygen delivery and inotropy in healthy term neonates with the Ultrasonic Cardiac Output Monitor (USCOM). Early Hum Dev. 2013;89(5):289–94.  https://doi.org/10.1016/j.earlhumdev.2012.10.006.CrossRefPubMedGoogle Scholar
  48. 48.
    McNamara H, Barclay P, Sharma V. Accuracy and precision of the ultrasound cardiac output monitor (USCOM 1A) in pregnancy: comparison with three-dimensional transthoracic echocardiography. Br J Anaesth. 2014;113(4):669–76.  https://doi.org/10.1093/bja/aeu162.CrossRefPubMedGoogle Scholar
  49. 49.
    Kupersztych-Hagege E, Teboul JL, Artigas A, Talbot A, Sabatier C, Richard C, et al. Bioreactance is not reliable for estimating cardiac output and the effects of passive leg raising in critically ill patients. Brit J Anaesth. 2013;111(6):961–6.  https://doi.org/10.1093/bja/aet282.CrossRefPubMedGoogle Scholar
  50. 50.
    Magliocca A, Rezoagli E, Anderson TA, Burns SM, Ichinose F, Chitilian HV. Cardiac output measurements based on the pulse wave transit time and thoracic impedance exhibit limited agreement with thermodilution method during orthotopic liver transplantation. Anesth Analg. 2017;  https://doi.org/10.1213/ANE.0000000000002171.
  51. 51.
    Elwan MH, Hue J, Green SJ, Eltahan SM, Sims MR, Coats TJ. Thoracic electrical bioimpedance versus suprasternal Doppler in emergency care. Emerg Med Australas. 2017;29(4):391–3.  https://doi.org/10.1111/1742-6723.12765.CrossRefPubMedGoogle Scholar
  52. 52.
    Maass SW, Roekaerts PM, Lancé MD. Cardiac output measurement by bioempedance and noninvasive pulse contour analysis compared with the continuous pulmonary artery thermodilution technique. J Cardiothorac Vasc Anesth. 2014;28(3):534–9.  https://doi.org/10.1053/j.jvca.2014.01.007.CrossRefPubMedGoogle Scholar
  53. 53.
    Bogui P, Balayssac-Siransy E, Connes P, Tuo N, Ouattara S, Pichon A, et al. The PhysioFlow thoracic impedance meter is not valid for the measurements of cardiac hemodynamic parameters in chronic anemic patients. PLoS One. 2013;8(10):e79086.  https://doi.org/10.1371/journal.pone.0079086.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Taylor K, Manlhiot C, McCrindle B, Grosse-Wortmann L, Holtby H. Poor accuracy of noninvasive cardiac output monitoring using bioimpedance cardiography [PhysioFlow(R)] compared to magnetic resonance imaging in pediatric patients. Anesth Analg. 2012;114(4):771–5.  https://doi.org/10.1213/ANE.0b013e318246c32c.CrossRefPubMedGoogle Scholar
  55. 55.
    Taylor K, La Rotta G, McCrindle BW, Manlhiot C, Redington A, Holtby H. A comparison of cardiac output by thoracic impedance and direct Fick in children with congenital heart disease undergoing diagnostic cardiac catheterization. J Cardiothorac Vasc Anesth. 2011;25(5):776–9.  https://doi.org/10.1053/j.jvca.2011.05.002.CrossRefPubMedGoogle Scholar
  56. 56.
    Sharma V, Singh A, Kansara B, Karlekar A. Comparison of transthoracic electrical bioempedance cardiac output measurement with thermodilution method in post coronary artery bypass graft patients. Ann Card Anaesth. 2011;14(2):104–10.  https://doi.org/10.4103/0971-9784.81564.CrossRefPubMedGoogle Scholar
  57. 57.
    Rodríguez-Artalejo F, Guallar E, Borghi C, Dallongeville J, De Backer G, Halcox JP, et al. Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA). BMC Public Health. 2010;10:382.  https://doi.org/10.1186/1471-2458-10-382.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Palafox B, Goryakin Y, Stuckler D, et al. Does greater individual social capital improve the management of hypertension? Cross-national analysis of 61,229 individuals in 21 countries. BMJ Glob Health. 2017;2(4):e000443.  https://doi.org/10.1136/bmjgh-2017-000443.eCollection2017.
  59. 59.
    Attaei MW, Khatib R, McKee M, PURE study investigators, et al. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet Public Health. 2017;2(9):e411–9.  https://doi.org/10.1016/S2468-2667(17)30141-X.CrossRefPubMedGoogle Scholar
  60. 60.
    Yusufali AM, Khatib R, Islam S, et al. Prevalence, awareness, treatment and control of hypertension in four Middle East countries. J Hypertens. 2017;35(7):1457–64.  https://doi.org/10.1097/HJH.0000000000001326.CrossRefPubMedGoogle Scholar
  61. 61.
    Tamblyn R, Winslade N, Qian CJ, Moraga T, Huang A. What is in your wallet? A cluster randomized trial of the effects of showing comparative patient out-of-pocket costs on primary care prescribing for uncomplicated hypertension. Implement Sci. 2018;13(1):7.  https://doi.org/10.1186/s13012-017-0701-x.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Laragh JH, Sealey JE. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure. Am J Hypertens. 2011;24(11):1164–80.  https://doi.org/10.1038/ajh.2011.171.CrossRefPubMedGoogle Scholar
  63. 63.
    Sealey JE, Alderman MH, Furberg CD, Laragh JH. Renin-angiotensin system blockers may create more risk than reward for sodium-depleted cardiovascular patients with high plasma renin levels. Am J Hypertens. 2013;26(6):727–38.  https://doi.org/10.1093/ajh/hpt034.CrossRefPubMedGoogle Scholar
  64. 64.
    McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson AB. Central blood pressure: current evidence and clinical importance. Eur Heart J. 2014;35(26):1719–25.  https://doi.org/10.1093/eurheartj/eht565.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Avolio A. Central aortic blood pressure and management of hypertension: confirmation of a paradigm shift? Hypertension. 2013;62(6):1005–7.  https://doi.org/10.1161/HYPERTENSIONAHA.113.02125.CrossRefPubMedGoogle Scholar
  66. 66.
    McEniery CM, Yasmin MDB, Munnery M, Wallace SM, Rowe CV, Cockcroft JR, et al. Central pressure: variability and impact of cardiovascular risk factors. The Anglo-Cardiff Collaborative Trial II. Hypertension. 2008;51:1476–82.  https://doi.org/10.1161/HYPERTENSIONAHA.107.105445.CrossRefPubMedGoogle Scholar
  67. 67.
    Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological aspects and clinical applications. Eur Heart J. 2006;27:2588–605.CrossRefPubMedGoogle Scholar
  68. 68.
    Sharman JE, Laurent S. Value of central blood pressure in the management of hypertension. J Human Hypertens. 2013;27:405–11.CrossRefGoogle Scholar
  69. 69.
    Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31:1865–71.CrossRefPubMedGoogle Scholar
  70. 70.
    Huang CM, Wang KL, Cheng HM, Chuang SY, Sung SH, Yu WC, et al. Central versus ambulatory blood pressure in the prediction of all-cause and cardiovascular mortalities. J Hypertens. 2011;29:454–9.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Cheng HM, Chuang SY, Sung SH, Yu WC, Pearson A, Lakatta EG, et al. Derivation and validation of diagnostic thresholds for central blood pressure measurements based on long-term cardiovascular risks. J Am Coll Cardiol. 2013;62:1780–7.CrossRefPubMedGoogle Scholar
  72. 72.
    Bakris G, Sorrentino M. Redefining hypertension—assessing the new blood-pressure guidelines. Editorial. N Engl J Med. 2018;378(6):498–9.  https://doi.org/10.1056/NEJMp1716193.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.School of MedicineUniversity of Notre Dame, AustraliaDarlinghurstAustralia
  2. 2.School of Biomedical ScienceCharles Sturt UniversityBathurstAustralia

Personalised recommendations